Prevalence and Management of Mucormycosis in India- A Post Pandemic Analysis

##plugins.themes.academic_pro.article.main##

1Neha Dubey
2Gaurav Dubey
3Dr. Ravi Ranjan
4Devanshi Dalal
5Arvind Singh
6Mahesh Chandra
7Vibha Kumari
8Jamshed Ali
9A.P Nishad Begum

Abstract

Background: The emergence of SARS-CoV-2 has increased Mucormycosis cases, which was perceived to be a rare infection caused by belligerent fungi belonging to order Mucorales. It is also called the black fungus and is exhibited as one of the seven variants such as rhino-cerebral, cutaneous, pulmonary, renal, gastrointestinal, disseminated or miscellaneous, leading to the debilitation of systemic wellness often associated with a reduction in functional efficiency and characterized by organ failure due to necrosis necessitating early diagnosis and timely treatment.


Aim: Hence, to sustain the quality of life during the pandemic, this review was aimed for a better understanding of Mucormycosis which is the need of the hour for efficient management to overcome global crises.


Materials and Methodology: A theoretical review was carried out on existing literature over three decades involving data in India as well as its global comparison, especially in terms of incidence and prevalence for enabling a scientifically evidence-based comprehensive analysis.


 Results: Indians have higher risk to Mucormycosis due to its large diabetic population when compared globally. It is evident that the rhino cerebral variant is the most commonly prevalent with a recent surge due to the pandemic. Conclusion: Both the incidence and prevalence of mucormycosis cases in India have always been very higher and has escalated even further due to the outbreak of SARS-CoV-2. It is recommended that appropriate modalities have to be adopted in individuals with immunocompromised conditions to safeguard them from contracting any reinfection as they are more susceptible to high-risk exposure.

##plugins.themes.academic_pro.article.details##

How to Cite
1Neha Dubey, 2Gaurav Dubey, 3Dr. Ravi Ranjan, 4Devanshi Dalal, 5Arvind Singh, 6Mahesh Chandra, 7Vibha Kumari, 8Jamshed Ali, & 9A.P Nishad Begum. (2024). Prevalence and Management of Mucormycosis in India- A Post Pandemic Analysis. International Journal of Medical Science in Clinical Research and Review, 7(03), Page: 404–415. Retrieved from http://ijmscrr.in/index.php/ijmscrr/article/view/761